The availability of gonadotropin therapy from FDA-approved pharmacies for men with hypogonadism and infertility.

There currently exists limited access to FDA-approved compounded gonadotropin therapies for hypogonadism and male infertility, and these results demonstrate the barriers to hCG and FSH access and the need for additional treatment options for this vulnerable patient population.